Martha Brumfield, Ph.D.
President and CEO
Critical Path Institute (C-Path)
Martha A. Brumfield, PhD, is President and Chief Executive Officer of Critical Path Institute, an
She also has her own consulting practice (Martha A. Brumfield LLC) focusing on concordance in global regulatory initiatives and regulatory science qualification programs. Other areas of focus in her practice include excellence in clinical trial conduct and pharmacovigilance, facilitation of scientific consortia and programs supporting patient access to medicines.
Brumfield brings 20 years of experience from Pfizer, Inc., most recently, as senior vice president of worldwide regulatory affairs and quality assurance. There, she led a global team that supported lifecycle pharmaceutical research, development and commercialization through creation and implementation of regulatory strategies and quality assurance oversight. Brumfield also played a key role in managing the broader company relationships with global regulators, trade associations, academics and others on regulatory policy issues. She served on corporate governance initiatives including the planning and implementation of mergers and acquisitions and led her departments through these periods of significant change.
She serves on the Board of Directors for the Regulatory Affairs Professional Society, participates in an advisory capacity to the Harvard Global Health Institute's
Brumfield earned a B.S. and an M.S. in chemistry from